Outcomes of First-Line Microwave Ablation of Treatment-Naive Epidermal Growth Factor Receptor–Mutated Advanced Lung Adenocarcinoma Treated with Tyrosine Kinase Inhibitors

To investigate the outcomes of first-line image-guided microwave ablation (MWA) plus tyrosine kinase inhibitors (TKIs) in untreated epidermal growth factor receptor (EGFR)-mutant advanced lung adenocarcinoma (LUAD), and to compare with TKIs alone.